These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9816014)

  • 21. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of transforming growth factor alpha and epidermal growth factor receptor in rat lung neoplasms induced by plutonium-239.
    Stegelmeier BL; Gillett NA; Hahn FF; Rebar AH; Kelly G
    Radiat Res; 1994 Nov; 140(2):191-8. PubMed ID: 7938468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L
    Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
    Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S; Zheng X; Carlsöö B
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potential transforming growth factor alpha/epidermal growth factor receptor autocrine circuit in placental cytotrophoblasts.
    Filla MS; Zhang CX; Kaul KL
    Cell Growth Differ; 1993 May; 4(5):387-93. PubMed ID: 8518231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
    Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
    Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
    Rubin Grandis J; Tweardy DJ; Melhem MF
    Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype.
    Di Marco E; Pierce JH; Fleming TP; Kraus MH; Molloy CJ; Aaronson SA; Di Fiore PP
    Oncogene; 1989 Jul; 4(7):831-8. PubMed ID: 2755700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
    Patel BJ; Pantuck AJ; Zisman A; Tsui KH; Paik SH; Caliliw R; Sheriff S; Wu L; deKernion JB; Tso CL; Belldegrun AS
    J Urol; 2000 Oct; 164(4):1420-5. PubMed ID: 10992426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
    Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
    Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-alpha and endocrine sensitivity in breast cancer.
    Nicholson RI; McClelland RA; Gee JM; Manning DL; Cannon P; Robertson JF; Ellis IO; Blamey RW
    Cancer Res; 1994 Apr; 54(7):1684-9. PubMed ID: 8137282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.